Host: |
Rabbit |
Applications: |
WB/IHC |
Reactivity: |
Human/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-CNPY2 (1-182) is suitable for use in Western Blot and Immunohistochemistry research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000IHC-P 1:50-1:200 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
CNPY2 |
Gene ID: |
10330 |
Uniprot ID: |
CNPY2_HUMAN |
Immunogen Region: |
1-182 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-182 of human CNPY2 (NP_055070.1). |
Immunogen Sequence: |
MKGWGWLALLLGALLGTAWA RRSQDLHCGACRALVDELEW EIAQVDPKKTIQMGSFRINP DGSQSVVEVPYARSEAHLTE LLEEICDRMKEYGEQIDPST HRKNYVRVVGRNGESSELDL QGIRIDSDISGTLKFACESI VEEYEDELIEFFSREADNVK DKLCSKRTDLCDHALHISHD EL |
Tissue Specificity | Expressed in different tissues. Highest levels are detected in adult placenta, liver and pancreas. |
Function | Positive regulator of neurite outgrowth by stabilizing myosin regulatory light chain (MRLC). It prevents MIR-mediated MRLC ubiquitination and its subsequent proteasomal degradation. |
Protein Name | Protein Canopy Homolog 2Mir-Interacting Saposin-Like ProteinPutative Secreted Protein Zsig9Transmembrane Protein 4 |
Cellular Localisation | Endoplasmic Reticulum |
Alternative Antibody Names | Anti-Protein Canopy Homolog 2 antibodyAnti-Mir-Interacting Saposin-Like Protein antibodyAnti-Putative Secreted Protein Zsig9 antibodyAnti-Transmembrane Protein 4 antibodyAnti-CNPY2 antibodyAnti-MSAP antibodyAnti-TMEM4 antibodyAnti-ZSIG9 antibodyAnti-UNQ1943 antibodyAnti-PRO4426 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance